Atossa Therapeutics, Inc. (ATOS) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18K | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | -100% | - | - | - | - | - | - |
| Cost of Goods Sold | 4K | 0 | 4K | 0 | 0 | 4K | 4K | 4K | 5K | 14K | 3K | 3K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | 77.78% | - | - |
| Gross Profit | -4K | 0 | -4K | 0 | 0 | -4K | -4K | -4K | -5K | -14K | -3K | -3K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | -77.78% | - | - |
| Gross Profit Growth % | - | 100% | 0% | 100% | 100% | 71.43% | -33.33% | -33.33% | -66.67% | -600% | -50% | -50% |
| Operating Expenses | 9.87M | 11.44M | 9.25M | 9.04M | 7.41M | 7.15M | 6.38M | 7.11M | 6.97M | 9.01M | 7.47M | 7.79M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | 50027.78% | - | - |
| Selling, General & Admin | 5.09M | 5.28M | 3.88M | 3.54M | 3.26M | 3.75M | 2.97M | 3.55M | 3.23M | 3.35M | 3M | 4.09M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | 18616.67% | - | - |
| Research & Development | 4.78M | 6.16M | 5.37M | 5.5M | 4.16M | 3.4M | 3.41M | 3.55M | 3.75M | 5.65M | 4.47M | 3.71M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | 31411.11% | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -4K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.87M | -11.44M | -9.25M | -9.04M | -7.41M | -7.15M | -6.38M | -7.11M | -6.98M | -9.02M | -7.47M | -7.79M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | -50105.56% | - | - |
| Operating Income Growth % | -33.13% | -59.92% | -44.89% | -27.23% | -6.22% | 20.71% | 14.5% | 8.83% | 1.66% | -10.83% | 8.98% | -18.17% |
| EBITDA | -9.87M | -11.43M | -9.25M | -9.04M | -7.41M | -7.15M | -6.38M | -7.1M | -6.97M | -9.01M | -7.46M | -7.79M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | -50027.78% | - | - |
| EBITDA Growth % | -33.14% | -59.96% | -44.91% | -27.25% | -6.24% | 20.63% | 14.52% | 8.84% | 1.69% | -10.68% | 9% | -18.16% |
| D&A (Non-Cash Add-back) | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 5K | 14K | 3K | 3K |
| EBIT | -9.87M | -11.44M | -8.69M | -9.04M | -7.41M | -7.15M | -6.38M | -7.11M | -6.98M | -7.75M | -7.47M | -7.79M |
| Net Interest Income | 309K | 442K | 570K | 645K | 720K | 837K | 1M | 1.07M | 1.14M | 416K | 1.27M | 983K |
| Interest Income | 309K | 442K | 570K | 645K | 720K | 837K | 1M | 1.07M | 1.14M | 1.24M | 1.27M | 983K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 820K | 0 | 0 |
| Other Income/Expense | 281K | 499K | 559K | 617K | 696K | 804K | -845K | 1.06M | 1.1M | 1.26M | 1.24M | -2.04M |
| Pretax Income | -9.59M | -10.94M | -8.69M | -8.42M | -6.72M | -6.35M | -7.23M | -6.05M | -5.88M | -7.75M | -6.23M | -9.83M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | -43077.78% | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -9.59M | -10.94M | -8.69M | -8.42M | -6.72M | -6.35M | -7.23M | -6.05M | -5.88M | -7.75M | -6.23M | -9.83M |
| Net Margin % | - | - | - | - | - | - | - | - | - | -43077.78% | - | - |
| Net Income Growth % | -42.74% | -72.32% | -20.22% | -39.25% | -14.29% | 18.15% | -16.07% | 38.46% | 6.42% | -3.51% | 22.24% | -47.33% |
| Net Income (Continuing) | -9.59M | -10.94M | -8.69M | -8.42M | -6.72M | -6.35M | -7.23M | -6.05M | -5.88M | -7.75M | -6.23M | -9.83M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.11 | -1.27 | -1.01 | -0.98 | -0.78 | -0.75 | -0.86 | -0.72 | -0.70 | -0.93 | -0.74 | -1.16 |
| EPS Growth % | -42.31% | -69% | -17.1% | -35.55% | -10.87% | 19.06% | -16.16% | 38.02% | 5.44% | -4.56% | 21.8% | -47.25% |
| EPS (Basic) | -1.11 | -1.27 | -1.01 | -0.98 | -0.78 | -0.75 | -0.86 | -0.72 | -0.70 | -0.93 | -0.74 | -1.16 |
| Diluted Shares Outstanding | 8.62M | 8.61M | 8.61M | 8.61M | 8.61M | 8.44M | 8.38M | 8.38M | 8.35M | 8.35M | 8.39M | 8.44M |
| Basic Shares Outstanding | 8.62M | 8.61M | 8.61M | 8.61M | 8.61M | 8.44M | 8.38M | 8.38M | 8.35M | 8.35M | 8.39M | 8.44M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |